EUCTR2006-005090-21-IT进行中（未招募）不适用
oradrenalin vs terlipressin in patients with hepatorenal syndrome - ND
AZIENDA SANITARIA OSPEDALIERA S. GIOVANNI BATTISTA DI TORINO0 个研究点开始时间: 2006年11月10日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •-All consecutive patients with hepaatorenal syndrome type 1 and 2 -Age between 18 and 75 years 3-Informed written consent 4-Absence of exclusion criteria
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- •-Age 75 years -Hepatocellular caarcinoma -Active bacterial infection -Gaastrointestinaal bleeding within the previous week -Hearth and respiratory failure - Distal arteriopathy - History of CAD - Arterial hypertension
研究者
相似试验
尚未招募
4 期
A study on the use of drugs like noradrenaline and vasopressin in managing hepatorenal issues associated with chronic liver diseaseCTRI/2024/05/067954Department of GI Surgery Amrita Hospital
已完成
3 期
Noradrenalin vs Terlipressin in Hepatorenal SyndromeHepatorenal SyndromeNCT00370253University of Turin, Italy20
已完成
不适用
Treatment for renal failure in chronic liver diseaseCTRI/2011/09/002032SKIMS university60
尚未招募
不适用
A clinical trial to study the efficiency of two drugs terlipressin and noradrenaline in patients with low blood pressure and liver failure.CTRI/2021/09/036920Pt BD Sharma Pgims rohtak
已完成
3 期
TYPE 2 HEPATORENAL SYNDROMESafety and Efficacy of Terlipressin and Noradrenaline and Predictive Factors of Response in Type 2 HRSNCT01637454Post Graduate Institute of Medical Education and Research, Chandigarh46